subject: PUBCHEM.COMPOUND:521372

object_name: Injury


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Trauma

tested_intervention: yes


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: Nausea gravidarum

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL2108465

object_name: hyperemesis gravidarum


subject: UNII:C5529G5JPQ

subject_name: ginger extract


subject: UNII:C5529G5JPQ


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Heart failure with normal ejection fraction


subject: UMLS:C0001645

object_name: diastolic heart failure


subject: UMLS:C3640211

subject_name: Multi-epitope Folate Receptor Alpha Peptide Vaccine

object_name: triple-negative breast carcinoma


subject: UMLS:C3640211

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C3640211

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3640211

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3640211

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3640211

object_name: Stage IIB Breast Carcinoma


subject: UMLS:C3640211

object_name: Stage IIA Breast Carcinoma


subject: UMLS:C3640211

object_name: bilateral breast carcinoma


subject: UMLS:C3640211

object_name: Unilateral Breast Carcinoma


subject: UMLS:C3640211

object_name: inflammatory breast carcinoma


subject: UNII:O4E1IFK37Y

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UMLS:C5417958

subject_name: HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: intestinal perforation


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Tourette syndrome


subject: CHEBI:17553


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:104747

object_name: gastric cancer


subject: CHEBI:17568

subject_name: Uracil


subject: CHEBI:17568


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: relapsing-remitting multiple sclerosis


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Residual Cancer


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: nonpapillary renal cell carcinoma


subject: UNII:PQX0D8J21J

object_name: clear cell renal carcinoma


subject: UNII:PQX0D8J21J

object_name: renal cell adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: renal cell carcinoma


subject: UNII:PQX0D8J21J

object_name: melanoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: prostatitis


subject: CHEBI:3160

object_name: Prostatitis category III (National Institute of Health classification)


subject: UMLS:C4744807

subject_name: Anti-CD46 Antibody-drug Conjugate FOR46

object_name: prostate carcinoma


subject: UMLS:C4744807

object_name: prostate cancer


subject: UMLS:C4744807

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: CHEBI:132922

object_name: Pregnant


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:161680

subject_name: Aztreonam


subject: UMLS:C5555006

object_name: Non-small cell lung cancer stage III


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: non-small cell lung carcinoma


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2919009

subject_name: Histamine-1 Receptor Inhibitor [EPC]


subject: UMLS:C3536871

subject_name: Histamine-1 Receptor Antagonist [EPC]


subject: UMLS:C0019593

subject_name: Histamine H2 Antagonists


subject: UMLS:C3536872

subject_name: Histamine-2 Receptor Antagonist [EPC]


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Primary amyloidosis of light chain type


subject: CHEBI:72690

object_name: AL amyloidosis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Embolism


subject: CHEBI:68579

object_name: Embolus


subject: DRUGBANK:DB14322

subject_name: Coconut oil

object_name: hyperlipidemia


subject: DRUGBANK:DB14322

object_name: Lipidemias


subject: DRUGBANK:DB14377

subject_name: Palm oil


subject: DRUGBANK:DB14377


subject: CHEBI:41423

subject_name: Celecoxib

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:41423

object_name: obesity


subject: CHEBI:41423

object_name: Obesity, CTCAE


subject: UMLS:C0445115

subject_name: Normal saline

object_name: neonatal respiratory failure


subject: CHEBI:66910

subject_name: Axitinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:66910

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:66910

object_name: Metastatic Uveal Melanoma


subject: CHEBI:66910

object_name: Melanoma recurrent


subject: CHEBI:66910

object_name: stage IIIB intraocular melanoma


subject: CHEBI:66910

object_name: stage IV intraocular melanoma


subject: CHEBI:66910

object_name: stage IIIC intraocular melanoma


subject: CHEBI:66910

object_name: stage IIIA intraocular melanoma


subject: CHEBI:66910

object_name: ocular melanoma with extraocular extension


subject: CHEBI:66910

object_name: Recurrent Uveal Melanoma


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Acute rhinosinusitis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: UNII:P826WR56FI

object_name: glucose metabolism disease


subject: UNII:P826WR56FI

object_name: diabetes mellitus


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931

object_name: type 2 diabetes mellitus


subject: CHEBI:6931


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Advanced Melanoma


subject: UMLS:C3827149


subject: UNII:T1DQI1B52Y

subject_name: Miransertib

object_name: hereditary endocrine growth disease


subject: UNII:T1DQI1B52Y

object_name: Proteus syndrome


subject: UMLS:C3274586

subject_name: ARQ 092


subject: UMLS:C3274586


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: pancreatic neoplasm


subject: UNII:37CQ2C7X93

object_name: exocrine pancreatic carcinoma


subject: UNII:37CQ2C7X93

object_name: malignant pancreatic neoplasm


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C2718754


subject: UMLS:C2718754


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:73571

subject_name: Leu-Phe-Asp

object_name: irritable bowel syndrome


subject: CHEBI:31431

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C0338133

subject_name: Gemzar


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: thyroid tumor


subject: GTOPDB:9758

object_name: thyroid gland carcinoma


subject: GTOPDB:9758

object_name: thyroid cancer


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UNII:5S371K6132


subject: HMDB:HMDB0015332

subject_name: Rifapentine

object_name: HIV infection


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: pediatric osteosarcoma


subject: CHEBI:231087

object_name: Osteosarcoma


subject: MESH:D000077203

subject_name: Sodium-Glucose Transporter 2 Inhibitors

object_name: heart failure


subject: MESH:D000077203

object_name: Heart Failure, CTCAE


subject: UMLS:C3542461

subject_name: Sodium-Glucose Cotransporter 2 Inhibitor [EPC]


subject: UMLS:C3542461


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: complications; artificial fertilization, introduction of embryo in embryo transfer


subject: UMLS:C0169964

subject_name: somatropin


subject: CHEBI:132967

subject_name: Elbasvir

object_name: hepatitis C virus, susceptibility to


subject: UMLS:C4760860

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: Fentanyl dependence


subject: CHEBI:7459

subject_name: Naloxone


subject: UMLS:C3858051

subject_name: ledipasvir / sofosbuvir

object_name: hepatitis C


subject: UMLS:C3858051

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:11332179

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:11332179

object_name: malignant pancreatic neoplasm


subject: CHEBI:72313

subject_name: pasireotide aspartate


subject: CHEBI:72313


subject: CHEBI:72313


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: UMLS:C1136845


subject: UNII:TT0V5JLG5B

subject_name: Avacincaptad pegol

object_name: Dry age-related macular degeneration


subject: CHEBI:9241

subject_name: Spironolactone

object_name: rheumatoid arthritis


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Tourette syndrome


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:76022323

object_name: diffuse large B-cell lymphoma


subject: CHEBI:9448

subject_name: Terbinafine

object_name: dermatomycosis


subject: CHEBI:9448

object_name: Itraconazole adverse reaction


subject: CHEBI:9448

object_name: Terbinafine adverse reaction


subject: UMLS:C4743011

object_name: Decreased liver function


subject: PUBCHEM.COMPOUND:3084049

subject_name: hyaluronan

object_name: Tissue Adhesion


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:132153

subject_name: hyaluronate


subject: UNII:U2H19X4WBV

subject_name: Tomivosertib

object_name: Childhood Breast Carcinoma


subject: UNII:U2H19X4WBV

object_name: breast carcinoma


subject: UNII:U2H19X4WBV

object_name: breast cancer


subject: PUBCHEM.COMPOUND:67395

object_name: Subfertility


subject: UMLS:C0112708

subject_name: Trelstar


subject: UMLS:C2001021

subject_name: CMX 157

object_name: infectious disease


subject: CHEBI:184472

subject_name: Nitrofurantoin

object_name: pelvic organ prolapse


subject: UMLS:C1328149

object_name: non-small cell lung carcinoma


subject: UMLS:C1328149

object_name: esophageal adenocarcinoma


subject: UMLS:C1328149

object_name: lung adenocarcinoma


subject: UMLS:C1328149

object_name: cervical adenocarcinoma


subject: UMLS:C1328149

object_name: adenocarcinoma


subject: UMLS:C1328149

object_name: bile duct adenocarcinoma


subject: UMLS:C1328149

object_name: gastric adenocarcinoma


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:66910


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: fallopian tube carcinoma


subject: CHEBI:231005

object_name: fallopian tube cancer


subject: CHEBI:231005

object_name: Recurrent ovarian cancer


subject: CHEBI:231005

object_name: peritoneum cancer


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: MESH:C476037

subject_name: PHY 906

object_name: diarrhea


subject: MESH:C476037

object_name: rectal discharge diarrhea (physical finding)


subject: MESH:C476037

object_name: Diarrhea, CTCAE


subject: MESH:C476037

object_name: colorectal neoplasm


subject: PUBCHEM.COMPOUND:91669168

subject_name: Zepatier

object_name: hepatitis C


subject: CHEBI:132973


subject: RXCUI:1734632

subject_name: elbasvir / grazoprevir Oral Product


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Fungemia


subject: CHEBI:10023

object_name: Fungemia, CTCAE


subject: CHEBI:10023

object_name: candidiasis


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: gastritis


subject: CHEBI:60648

object_name: Gastritis, CTCAE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:50275

subject_name: Esomeprazole


subject: CHEBI:50275


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:63598


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage III Lung Cancer


subject: UMLS:C3641122


subject: UMLS:C0250480

subject_name: piperacillin-tazobactam combination

object_name: leukopenia


subject: UMLS:C0250480

object_name: neutropenia


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: esophageal disorder


subject: UNII:4R4HFI6D95

subject_name: polyethylene glycol 4000

object_name: Constipation


subject: UNII:4R4HFI6D95

object_name: Constipation, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2074863


subject: CHEMBL.COMPOUND:CHEMBL2074863


subject: CHEBI:15927

subject_name: Nicotinamide riboside

object_name: ataxia telangiectasia


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Pinhole meatus


subject: CHEBI:3077

object_name: Male urethral meatus stenosis


subject: PUBCHEM.COMPOUND:5466794

subject_name: Flavopiridol

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:5466794

object_name: sarcoma


subject: CHEBI:47344

subject_name: Alvocidib


subject: CHEBI:47344


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: nephrolithiasis


subject: UNII:6GNT3Y5LMF


subject: CHEBI:63598


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Myelodysplasia


subject: UNII:4Z63YK6E0E

object_name: Adult Myelodysplastic Syndrome


subject: UNII:4Z63YK6E0E

object_name: childhood myelodysplastic syndrome


subject: UNII:4Z63YK6E0E

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:4Z63YK6E0E

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:32181

subject_name: Tamibarotene


subject: CHEBI:32181


subject: CHEBI:32181


subject: CHEBI:32181


subject: UMLS:C4329994

subject_name: Fluorescent Dye LS301

object_name: Stomach cancer


subject: UMLS:C4329994

object_name: gastric cancer


subject: UMLS:C4329994

object_name: pancreatic neoplasm


subject: UMLS:C4329994

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4329994

object_name: malignant pancreatic neoplasm


subject: UMLS:C4329994

object_name: liver cancer


subject: UMLS:C4329994

object_name: liver neoplasm


subject: UMLS:C4329994

object_name: Adult Liver Carcinoma


subject: UMLS:C4329994

object_name: liver carcinoma


subject: UMLS:C4329994

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4329994

object_name: Embolism, Tumor


subject: UMLS:C4329994

object_name: Neoplasm Metastasis


subject: UMLS:C4329994

object_name: Gastrointestinal stromal cancer


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: Blood Clot


subject: KEGG.COMPOUND:C00374

object_name: thrombosis


subject: KEGG.COMPOUND:C00374

object_name: Thrombosis of blood vessel


subject: CHEBI:190735

subject_name: Arbaclofen

object_name: Spasticity, CTCAE


subject: CHEBI:190735

object_name: Spasticity


subject: CHEBI:74705

subject_name: Met-Leu

object_name: chronic kidney disease


subject: CHEBI:74705

object_name: Chronic Kidney Disease, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PUBCHEM.COMPOUND:6917964

subject_name: OCTREOTIDE ACETATE

object_name: acromegaly


subject: PUBCHEM.COMPOUND:6917964

object_name: Acral overgrowth


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:11306691

object_name: coronary atherosclerosis


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: gout tophaceous


subject: UNII:4F4X42SYQ6

object_name: gout


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:9150

subject_name: Simvastatin

object_name: acute respiratory distress syndrome


subject: CHEBI:9150

object_name: acute lung injury


subject: CHEBI:9150

object_name: adult acute respiratory distress syndrome


subject: CHEBI:9150

object_name: Adult Respiratory Distress Syndrome, CTCAE


subject: DRUGBANK:DB13959

subject_name: Medium-chain triglycerides

object_name: pancreatic neoplasm


subject: DRUGBANK:DB13959

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB13959

object_name: gastric neoplasm


subject: DRUGBANK:DB13959

object_name: liver neoplasm


subject: PR:000010231

subject_name: malonyl-CoA-acyl carrier protein transacylase, mitochondrial


subject: PR:000010231


subject: PR:000010231


subject: PR:000010231


subject: PR:000022561

subject_name: malonyl CoA-acyl carrier protein transacylase


subject: PR:000022561


subject: PR:000022561


subject: PR:000022561


subject: PR:000023036


subject: PR:000023036


subject: PR:000023036


subject: PR:000023036


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: CHEMBL.COMPOUND:CHEMBL3833369


subject: MESH:C568345

subject_name: fish oil triglycerides

object_name: Essential fatty acid deficiency


subject: MESH:C568345

object_name: childhood acute lymphoblastic leukemia


subject: MESH:C568345

object_name: malnutrition


subject: PUBCHEM.COMPOUND:9832423

subject_name: Vytorin

object_name: Inflammation


subject: RXCUI:476348

subject_name: ezetimibe / simvastatin Oral Tablet


subject: UMLS:C5666876

subject_name: BRAF V600E Inhibitor HLX208

object_name: Langerhans cell histiocytosis


subject: UMLS:C5666876

object_name: Langerhans cell histiocytosis specific to childhood


subject: UMLS:C5666876

object_name: Langerhans cell histiocytosis specific to adulthood


subject: UMLS:C5666876

object_name: Erdheim-Chester disease


subject: UMLS:C5666876

object_name: familial atrioventricular septal defect


subject: UMLS:C5666876

object_name: split hand-foot malformation 1


subject: UMLS:C5666876

object_name: lissencephaly with cerebellar hypoplasia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: acute myocardial infarction


subject: UNII:PVI5M0M1GW

object_name: Acute Myocardial Infarction by ECG Finding


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: pneumocystosis


subject: UMLS:C3540708

object_name: Pneumocystis jirovecii pneumonia


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: CHEBI:50858

subject_name: corticosteroid


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: UMLS:C2984025

subject_name: Ferinject

object_name: Advanced gastric carcinoma


subject: CHEBI:17968

subject_name: butyrate

object_name: ulcerative colitis


subject: CHEBI:17968

object_name: inflammatory bowel disease 1


subject: MESH:D002087

subject_name: Butyrates


subject: MESH:D002087


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772


subject: CHEBI:64019

subject_name: Nebivolol

object_name: HER2 positive breast carcinoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: neuralgia


subject: CHEBI:6121

object_name: Neuralgia, CTCAE


subject: CHEBI:58097

object_name: Shoulder pain


subject: CHEBI:17303

subject_name: Morphine


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:5066234

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:5066234

object_name: oral sensibility, disturbance of


subject: UMLS:C1161331

subject_name: Saccharum officinale, sucrose, cane sugar, Homeopathic preparation


subject: UMLS:C1161331


subject: CHEBI:17992

subject_name: Sucrose


subject: CHEBI:17992


subject: CHEBI:18167

subject_name: alpha-maltose


subject: CHEBI:18167


subject: CHEBI:18167


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEMBL.COMPOUND:CHEMBL2107951


subject: CHEBI:45615

subject_name: Salicylhydroxamic Acid

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:5520

subject_name: gonadorelin


subject: PR:000008127


subject: UMLS:C0243071

subject_name: Analog


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro


subject: CHEBI:17347

subject_name: Testosterone


subject: UNII:O28XHZ9UQ4


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694


subject: CHEBI:178199

subject_name: Sotorasib

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: CHEBI:178199

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:178199

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: CHEBI:32127

subject_name: sevelamer

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:GLS2PGI8QG

subject_name: SEVELAMER HYDROCHLORIDE

object_name: chronic kidney disease


subject: UNII:GLS2PGI8QG


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: CHEBI:4784

subject_name: Enalapril

object_name: kidney disorder


subject: CHEBI:4784

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:3222


subject: PUBCHEM.COMPOUND:3222


subject: UMLS:C0600128

subject_name: Renitec

object_name: hypertension


subject: UMLS:C0600128

object_name: Hypertension, CTCAE


subject: UMLS:C0600128


subject: UMLS:C0600128


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:27470


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: chronic obstructive pulmonary disease


subject: CHEBI:60648

object_name: Inflammation


subject: CHEBI:60648

object_name: emphysema


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:9757

subject_name: Tropicamide

object_name: Mydriasis


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:74825

subject_name: Thr-Arg


subject: PR:000001661

subject_name: proteinase-activated receptor 1


subject: PR:000016871

subject_name: thioredoxin reductase 1, cytoplasmic


subject: PR:000001945

subject_name: transferrin receptor protein 1


subject: CHEBI:25902

subject_name: pentyl group


subject: CHEBI:17553


subject: CHEBI:74762

subject_name: Pro-Glu


subject: CHEBI:16038

subject_name: phosphatidylethanolamine


subject: PR:000013200

subject_name: prolyl endopeptidase


subject: UMLS:C3640299

subject_name: Osteodex

object_name: metastatic prostate carcinoma


subject: CHEBI:9316

subject_name: Sufentanil

object_name: no feeling or sensation of skin


subject: CHEBI:9316

object_name: Sensory Loss


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel

object_name: High grade B-cell lymphoma recurrent


subject: DRUGBANK:DB16582

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: DRUGBANK:DB16582

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: DRUGBANK:DB16582

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: DRUGBANK:DB16582

object_name: Refractory Indolent B-Cell Non-Hodgkin Lymphoma


subject: DRUGBANK:DB16582

object_name: Refractory Grade 3b Follicular Lymphoma


subject: DRUGBANK:DB16582

object_name: Recurrent Indolent B-Cell Non-Hodgkin Lymphoma


subject: DRUGBANK:DB16582

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314892

subject_name: VEVOCTADEKIN

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314892

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314892

object_name: High grade B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: CHEMBL.COMPOUND:CHEMBL5314892


subject: UMLS:C5557203

subject_name: Vevoctadekin


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: UMLS:C5557203


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: biliary atresia


subject: PUBCHEM.COMPOUND:6096882

object_name: Cholestasis in newborn


subject: PUBCHEM.COMPOUND:6096882

object_name: Cholestasis in newborn infant


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: low tension glaucoma


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE


subject: PUBCHEM.COMPOUND:11236066

object_name: open-angle glaucoma


subject: CHEBI:3175

subject_name: Brimonidine


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Drug Interactions


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Child Malnutrition


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: paroxysmal familial ventricular fibrillation


subject: UMLS:C2757070

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: asthma


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Huntington disease


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: PUBCHEM.COMPOUND:188218

object_name: common wart


subject: UMLS:C0608016


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:141969


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: clubfoot


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Lymphoma, Low-Grade


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721495

subject_name: Astugenal


subject: CHEBI:49956

subject_name: Xenon

object_name: hypersensitivity pneumonitis


subject: CHEBI:49956

object_name: interstitial lung disease 1


subject: CHEBI:49956

object_name: interstitial lung disease 2


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: glioblastoma


subject: UNII:52CMI0WC3Y

object_name: Brain Stem Glioblastoma


subject: UNII:52CMI0WC3Y

object_name: glioma susceptibility 1


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: DRUGBANK:DB17296

subject_name: Gebasaxturev

object_name: melanoma


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: anxiety


subject: UMLS:C3248676

object_name: anxiety disorder


subject: UMLS:C3248676

object_name: Anxiety symptoms


subject: UMLS:C3248676

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C3248676

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: GTOPDB:13792

subject_name: iparomlimab

object_name: liver carcinoma


subject: UNII:FN3VWV28BC

subject_name: IPAROMLIMAB


subject: UMLS:C5669553

subject_name: Iparomlimab


subject: UNII:5EZ01YDT5S

subject_name: Runcaciguat

object_name: chronic kidney disease


subject: UNII:5EZ01YDT5S

object_name: Chronic Kidney Disease, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL4297686

subject_name: IZOKIBEP

object_name: uveitis


subject: CHEMBL.COMPOUND:CHEMBL4297686

object_name: Uveitis, CTCAE


subject: UMLS:C5421163

subject_name: Izokibep


subject: UMLS:C5421163


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Gaucher disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: Childhood Breast Carcinoma


subject: UMLS:C4033631

object_name: breast carcinoma


subject: UMLS:C4033631

object_name: breast cancer


subject: UMLS:C4033631

object_name: cardiotoxicity


subject: UMLS:C4033631

object_name: Treatment related secondary malignancy


subject: UMLS:C4033631

object_name: breast disorder


subject: UMLS:C4033631

object_name: breast neoplasm


subject: UNII:0Y70779M1F

subject_name: Botulinum toxin type B

object_name: Low back pain


subject: UMLS:C0006051


subject: UNII:788PET5SUA

subject_name: Basmisanil

object_name: schizophrenia


subject: UMLS:C4283878

subject_name: Neutrophil Activation Probe Imaging Agent

object_name: lung disorder


subject: PR:000010986

subject_name: napsin-A


subject: PR:000006011

subject_name: beta-catenin-like protein 1


subject: UMLS:C5401490

subject_name: Bite brandname of antibiotic

object_name: leukemia


subject: UMLS:C5401490

object_name: childhood leukemia


subject: UMLS:C5401490

object_name: Recurrent disease


subject: UMLS:C5401490

object_name: Global Relapse in Viscera


subject: UMLS:C5401490

object_name: Global Relapse in Lymph Nodes


subject: UMLS:C5401490

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UMLS:C5401490

object_name: Global Relapse


subject: UMLS:C5401490

object_name: Global Relapse in Skin


subject: UMLS:C5401490

object_name: Global Relapse in Blood


subject: PR:000005355

subject_name: centrosomal protein of 70 kDa


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: PR:000005355


subject: GTOPDB:11649

subject_name: feladilimab

object_name: plasma cell myeloma


subject: UNII:OUP4QB2A3R

subject_name: FELADILIMAB


subject: UMLS:C4287758

subject_name: Feladilimab


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB10640

object_name: Diabetes


subject: DRUGBANK:DB10640

object_name: diabetes mellitus


subject: DRUGBANK:DB10640

object_name: hypertension


subject: DRUGBANK:DB10640

object_name: Hypertension, CTCAE


subject: UMLS:C4287716

object_name: rheumatoid arthritis


subject: CHEBI:39585

subject_name: Carbidopa

object_name: red-green color blindness


subject: CHEBI:39585

object_name: Deuteranomaly


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:521372


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: salivary gland carcinoma


subject: CHEBI:72317

object_name: salivary gland cancer


subject: UMLS:C5432265

subject_name: Goflikicept

object_name: adult-onset Still disease


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: parapsoriasis


subject: CHEBI:3892

subject_name: Corticotropin

object_name: Sarcoid uveitis


subject: UMLS:C5201181

subject_name: H.P. acthar gel


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Intravenous Drug Usage


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Hypercalciuria


subject: CHEBI:89324

object_name: hypoparathyroidism


subject: CHEBI:89324

object_name: Hypoparathyroidism, CTCAE


subject: CHEBI:89324

object_name: hypercalcemia


subject: CHEBI:89324

object_name: Hypercalcemia, CTCAE


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: CHEBI:9139

subject_name: Sildenafil

object_name: premature ejaculation


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: focal epilepsy


subject: CHEBI:132986

subject_name: Sapitinib

object_name: Childhood Breast Carcinoma


subject: CHEBI:132986

object_name: breast carcinoma


subject: CHEBI:132986

object_name: breast cancer


subject: CHEBI:132986

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:132986

object_name: Embolism, Tumor


subject: CHEBI:132986

object_name: Neoplasm Metastasis


subject: CHEBI:132986

object_name: neoplasm


subject: MESH:C548875


subject: MESH:C548875


subject: MESH:C548875


subject: MESH:C548875


subject: MESH:C548875


subject: MESH:C548875


subject: MESH:C548875


subject: UMLS:C4744807

subject_name: Anti-CD46 Antibody-drug Conjugate FOR46

object_name: plasma cell myeloma


subject: UMLS:C4744807

object_name: Relapse multiple myeloma


subject: UMLS:C4744807

object_name: Plasma cell myeloma recurrent


subject: UMLS:C4744807

object_name: Multiple myeloma, without mention of having achieved remission


subject: CHEBI:191502

subject_name: MS 3

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:191502

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:191502

object_name: chronic myelomonocytic leukemia


subject: CHEBI:191502

object_name: Myelodysplasia


subject: CHEBI:2687

subject_name: Amsacrine


subject: CHEBI:2687


subject: CHEBI:2687


subject: CHEBI:2687


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C0733521


subject: UMLS:C0733521


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: adult acute myeloid leukemia


subject: CHEBI:231651

object_name: childhood acute myeloid leukemia


subject: CHEBI:231651

object_name: Treatment related acute myeloid leukaemia


subject: CHEBI:231651


subject: CHEBI:231651


subject: CHEBI:231651

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:231651

object_name: myeloid sarcoma


subject: CHEBI:231651


subject: UMLS:C4085979

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:9123

subject_name: Sertraline

object_name: panic disorder


subject: CHEBI:9123

object_name: panic disorder 1


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: wet macular degeneration


subject: CHEBI:30496

object_name: Submacular hemorrhage


subject: CHEBI:30496

object_name: eye disorder


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA


subject: PUBCHEM.COMPOUND:22976653


subject: PUBCHEM.COMPOUND:22976653


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: CHEBI:6931

subject_name: Midazolam

object_name: psoriasis


subject: UNII:TWQ8K8A81Y

subject_name: Larotaxel

object_name: Carcinoma breast stage IV


subject: UNII:TWQ8K8A81Y

object_name: Advanced breast cancer


subject: UNII:TWQ8K8A81Y

object_name: Childhood Breast Carcinoma


subject: UNII:TWQ8K8A81Y

object_name: breast carcinoma


subject: UNII:TWQ8K8A81Y

object_name: breast cancer


subject: UMLS:C2603884


subject: UMLS:C2603884


subject: UMLS:C2603884


subject: UMLS:C2603884


subject: UMLS:C2603884


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: ovarian carcinoma


subject: UNII:98DE7VN88D

object_name: malignant epithelial tumor of ovary


subject: UNII:98DE7VN88D

object_name: primary peritoneal carcinoma


subject: UNII:98DE7VN88D

object_name: Primary Peritoneal Cancer


subject: UNII:98DE7VN88D

object_name: fallopian tube carcinoma


subject: UNII:98DE7VN88D

object_name: fallopian tube cancer


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: UMLS:C3640818


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: myopathy


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C2093603

subject_name: Rabbit


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:152165

object_name: rheumatoid arthritis


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Catheter related infection


subject: CHEBI:74705

object_name: Catheter Related Infection, CTCAE


subject: CHEBI:74705

object_name: bacteriemia


subject: CHEBI:74705

object_name: Bacteremia, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:233364

subject_name: Bryostatin

object_name: renal carcinoma


subject: CHEBI:233364

object_name: kidney neoplasm


subject: CHEBI:233364

object_name: kidney cancer


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Angina pectoris


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Recurrence


subject: UNII:28X28X9OKV

object_name: Recurrent Malignant Neoplasm


subject: UNII:28X28X9OKV

object_name: Recurrent disease


subject: UNII:28X28X9OKV

object_name: Recurrent tumor


subject: UNII:28X28X9OKV

object_name: Metastasis


subject: UNII:28X28X9OKV

object_name: Metastatic Lesion


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: DRUGBANK:DB10638

subject_name: Artichoke

object_name: Inflammation


subject: DRUGBANK:DB10638

object_name: Hypercholesterolemia


subject: UMLS:C4282062

subject_name: Cynara scolymus whole extract


subject: UMLS:C4282062


subject: UNII:1693AM5SBN

subject_name: Salvia miltiorrhiza root


subject: UNII:1693AM5SBN


subject: UNII:39W1PKE3JI

subject_name: Bergamot oil


subject: UNII:39W1PKE3JI


subject: UMLS:C3715207

subject_name: bergamot orange extract


subject: UMLS:C3715207


subject: UMLS:C5700201

subject_name: Citrus bergamia oil


subject: UMLS:C5700201


subject: CHEBI:27470

subject_name: Folic acid


subject: UMLS:C2348261

subject_name: Dietary Chromium


subject: UMLS:C2348261


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:28073


subject: CHEBI:49544

subject_name: Chromic cation


subject: CHEBI:49544


subject: PUBCHEM.COMPOUND:152165

object_name: Primary dysmenorrhea


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:8249

subject_name: Piroxicam


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: intraocular lymphoma


subject: PR:000003914

subject_name: AKT-interacting protein

object_name: Diarrhea caused by drug


subject: CHEBI:5441

subject_name: Glyburide

object_name: Gestational diabetes mellitus in pregnancy


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: Kinetic tremor


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: cardiovascular disorder


subject: UMLS:C4521460

subject_name: Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


subject: UMLS:C1328123

subject_name: Allogeneic Tumor Cell Vaccine

object_name: malignant soft tissue neoplasm


subject: UMLS:C1328123

object_name: sarcoma


subject: UMLS:C1328123

object_name: melanoma


subject: CHEBI:41423

subject_name: Celecoxib


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: neoplasm


subject: CHEBI:145371

subject_name: Binimetinib

object_name: cancer


subject: CHEBI:145371


subject: CHEBI:177793

subject_name: Atopaxar

object_name: acute coronary syndrome


subject: CHEBI:48045

subject_name: Marizomib

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:48045

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:48045

object_name: Diffuse Glioma


subject: CHEBI:48045

object_name: childhood malignant neoplasm


subject: CHEBI:48045

object_name: Childhood Brain Neoplasm


subject: CHEBI:48045

object_name: childhood brain stem glioma


subject: CHEBI:48045

object_name: Recurrent Childhood Brain Stem Glioma


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:52CMI0WC3Y

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Malignant Solid Neoplasm


subject: UNII:52CMI0WC3Y


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: Lung Injury


subject: UMLS:C4044724


subject: UMLS:C5238973

subject_name: Anti-PD-1/CD47 Fusion Protein HX009

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Chronic Exertional Compartment Syndrome


subject: CHEBI:93775

subject_name: Amethopterin

object_name: sarcoidosis


subject: CHEBI:93775

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:93775

object_name: cardiac sarcoidosis


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:15365

subject_name: Aspirin

object_name: Adenomatous Polyps


subject: CHEBI:41948

subject_name: Eflornithine


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: aortic valve disease 2


subject: PUBCHEM.COMPOUND:9824461

object_name: aortic stenosis


subject: PUBCHEM.COMPOUND:9824461

object_name: aortic valve disease 3


subject: PUBCHEM.COMPOUND:9824461

object_name: Stenosis of aorta


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: allergic bronchopulmonary aspergillosis


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: CHEBI:135014

subject_name: Erdosteine

object_name: chronic obstructive pulmonary disease


subject: CHEBI:135014

object_name: chronic bronchitis


subject: CHEBI:135014

object_name: bronchitis


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: mucocutaneous lymph node syndrome


subject: UMLS:C4721495

subject_name: Astugenal

object_name: adult brainstem glioma


subject: UMLS:C4721495

object_name: childhood brain stem glioma


subject: UMLS:C4721495

object_name: brain stem glioma


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10


subject: UNII:16VY3TM7ZO


subject: UNII:16VY3TM7ZO


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721487


subject: UMLS:C4053685

object_name: plasma cell myeloma


subject: CHEBI:7936

subject_name: Paroxetine

object_name: social phobia


subject: CHEBI:95165

object_name: breast neoplasm


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: sinusitis


subject: CHEBI:51254

object_name: Acute sinusitis


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: coronavirus as cause of disease classified elsewhere


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: Metastatic Carcinoma to the Uterine Cervix


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Advanced cancer


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEBI:64198

subject_name: Dimercaprol


subject: CHEBI:64198


subject: PR:000015049

subject_name: long-chain fatty acid transport protein 5


subject: PR:000015049


subject: PR:000012301


subject: PR:000012301


subject: PR:000005317

subject_name: bile salt-activated lipase


subject: PR:000005317


subject: CHEBI:8364

subject_name: Prazosin

object_name: insomnia


subject: CHEBI:8364

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:8364

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:8364

object_name: nightmare


subject: CHEBI:8364

object_name: Nightmare disorder


subject: CHEBI:8364

object_name: anxiety disorder


subject: CHEBI:8364

object_name: mood disorder


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: Rhabdomyolysis Related to COVID-19


subject: PUBCHEM.COMPOUND:126456119

object_name: Rhabdomyolysis, CTCAE


subject: PUBCHEM.COMPOUND:126456119

object_name: Rhabdomyolysis


subject: PR:000009978

subject_name: lactotransferrin


subject: PR:000009978


subject: PR:000009978


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UMLS:C0022942


subject: UMLS:C0022942


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: UniProtKB:Q8TCD2


subject: UniProtKB:Q8TCD2


subject: CHEBI:17754

subject_name: Glycerin


subject: CHEBI:17754


subject: CHEBI:17754


subject: UMLS:C0002763

subject_name: Central Nervous System Stimulants

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C0002763


subject: UMLS:C0304402

subject_name: Stimulant


subject: UMLS:C0304402


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:165874

object_name: ovarian carcinoma


subject: CHEBI:165874

object_name: malignant epithelial tumor of ovary


subject: CHEBI:165874

object_name: ovarian cancer


subject: CHEBI:165874

object_name: ovarian neoplasm


subject: UMLS:C1831611

object_name: neoplasm


subject: UNII:G55ZH52P57

object_name: pulmonary tuberculosis


subject: UNII:43EP6XV33E

subject_name: Delpazolid


subject: UNII:KZ8H57WFC7

subject_name: GANFEBOROLE


subject: UMLS:C5855335

subject_name: Ganfeborole


subject: CHEBI:32019

subject_name: Piromidic acid


subject: CHEBI:133659

subject_name: Pro-Ala


subject: CHEBI:33386

subject_name: Protactinium


subject: CHEBI:30745

subject_name: Phenylacetic acid


subject: CHEBI:8428

subject_name: Procainamide


subject: CHEBI:7959

subject_name: Penicillamine


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:30768

subject_name: Propanoic acid


subject: PR:000049747

subject_name: influenzavirus PA gene translation product


subject: PR:000004008

subject_name: alpha-amylase 2A


subject: PR:000012849

subject_name: biogenesis of lysosome-related organelles complex 1 subunit 6


subject: PR:000013209

subject_name: salivary acidic proline-rich phosphoprotein


subject: UNII:1PQN78P4S3

subject_name: Quabodepistat


subject: CHEBI:61397

subject_name: Neratinib

object_name: breast neoplasm


subject: MESH:C000730636

object_name: Parkinson disease


subject: UMLS:C3275038

subject_name: COMBIG-DC

object_name: liver carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Renal Failure, CTCAE


subject: CHEBI:66910

subject_name: Axitinib

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:66910

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:66910

object_name: sarcoma


subject: CHEBI:66910

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:66910

object_name: soft tissue sarcoma


subject: UMLS:C0114857

subject_name: Dotarem

object_name: cerebral arterial disease


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Intubation complication


subject: PUBCHEM.COMPOUND:135718449

object_name: no feeling or sensation of skin


subject: PUBCHEM.COMPOUND:135718449

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:135718449

object_name: Neuromuscular inhibition


subject: PUBCHEM.COMPOUND:135718449

object_name: Neuromuscular block, function


subject: PUBCHEM.COMPOUND:135718449

object_name: Postoperative Residual Curarization


subject: PUBCHEM.COMPOUND:135718449


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: spinal cord injury


subject: UNII:1C6V77QF41

object_name: Head Injury


subject: UNII:1C6V77QF41

object_name: brain aneurysm


subject: UNII:1C6V77QF41

object_name: Intracranial hemorrhage


subject: UNII:1C6V77QF41

object_name: brain cancer


subject: UNII:1C6V77QF41

object_name: brain neoplasm


subject: UNII:1C6V77QF41

object_name: meningitis


subject: UNII:1C6V77QF41

object_name: Meningitis, CTCAE


subject: UNII:1C6V77QF41

object_name: Seizure Related to COVID-19


subject: UNII:1C6V77QF41

object_name: epilepsy


subject: UNII:1C6V77QF41

object_name: visual epilepsy


subject: UNII:1C6V77QF41

object_name: stroke disorder


subject: UNII:1C6V77QF41

object_name: cerebrovascular disorder


subject: UNII:1C6V77QF41

object_name: Stroke (heart beat)


subject: UNII:1C6V77QF41

object_name: Stroke, CTCAE


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: lupus nephritis


subject: UMLS:C0378942


subject: UMLS:C5435290

object_name: atopic eczema


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: infective vaginitis


subject: UNII:L500PR95QA

object_name: Vaginal Infection, CTCAE


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Infection


subject: PUBCHEM.COMPOUND:76322320

object_name: infectious disease


subject: PUBCHEM.COMPOUND:76322320

object_name: Adverse Event Associated with Infection


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:37943


subject: CHEBI:37943


subject: PUBCHEM.COMPOUND:9861622

subject_name: Ecopipam

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:9861622

object_name: Adverse drug interaction


subject: UMLS:C1439313

object_name: hypertension


subject: UMLS:C1439313

object_name: Hypertension, CTCAE


subject: CHEBI:95060

subject_name: Dinaciclib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Niemann-Pick disease


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: total parenteral nutrition-induced cholestasis


subject: UMLS:C3640943

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: PUBCHEM.COMPOUND:18943906

subject_name: Ibuprofen Ibuprofen Ibuprofen

object_name: Acute low back pain


subject: PUBCHEM.COMPOUND:18943906

object_name: Low back pain


subject: PUBCHEM.COMPOUND:18943906

object_name: Low Back Pain, Mechanical


subject: CHEBI:47835

subject_name: levibuprofen


subject: CHEBI:47835


subject: CHEBI:47835


subject: UMLS:C1722261

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C1722261

object_name: COPD, severe early onset


subject: UMLS:C1722261

object_name: chronic obstructive pulmonary disease


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UNII:939U7C91AI


subject: CHEBI:78538

object_name: Hereditary Transthyretin Amyloidosis with Polyneuropathy


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Repeated implantation failure


subject: CHEBI:2948

object_name: Encounter due to In vitro fertilization


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Heart Disease Risk Factors


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C4763757

subject_name: Erfonrilimab

object_name: non-small cell lung carcinoma


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: NK-cell lymphoma


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:64816

object_name: T-Cell Lymphoma


subject: CHEBI:64816

object_name: anaplastic large cell lymphoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: UMLS:C0729218

object_name: lupus nephritis


subject: UMLS:C0729218

object_name: kidney disorder


subject: CHEBI:164200

subject_name: Triclosan

object_name: periodontitis


subject: UMLS:C0596383

subject_name: Copolymer


subject: CHEBI:53310

subject_name: copolymer macromolecule


subject: CHEBI:60804

subject_name: copolymer


subject: CHEBI:29228

subject_name: FLUORIDE


subject: CHEBI:17051

subject_name: Fluoride ion


subject: UMLS:C3541971

subject_name: Fluoride supplements


subject: UMLS:C3714616

subject_name: Fluoride Drug Class


subject: UMLS:C5392300

object_name: Coronavinae infectious disease


subject: CHEBI:180653

subject_name: Molnupiravir


subject: CHEBI:9635

subject_name: Toremifene

object_name: Childhood Breast Carcinoma


subject: CHEBI:9635

object_name: breast carcinoma


subject: CHEBI:9635

object_name: breast cancer


subject: CHEBI:78825

subject_name: Avutometinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:78825

object_name: melanoma


subject: CHEBI:78825

object_name: skin melanoma


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: CHEBI:85980

subject_name: Eluxadoline

object_name: Irritable bowel syndrome with diarrhea


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: sickle cell disease


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:71219

object_name: stage III adult soft tissue sarcoma


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol

object_name: lung cancer


subject: PUBCHEM.COMPOUND:3080587

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:3080587

object_name: lung carcinoma


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: adult liposarcoma


subject: UMLS:C4331803

object_name: liposarcoma


subject: UMLS:C4331803

object_name: pediatric liposarcoma


subject: UMLS:C4331803

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: chronic graft versus host disease


subject: UNII:QQA9MLH692

object_name: Steroid Refractory Graft Versus Host Disease


subject: UNII:QQA9MLH692

object_name: hematologic disorder


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C4688441

subject_name: Promenakin

object_name: acute graft vs. host disease


subject: UMLS:C4688441

object_name: acute graft versus host disease


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: cervical cancer


subject: CHEBI:5864

object_name: cervical carcinoma


subject: CHEBI:46987

subject_name: L-ARABINOSE

object_name: Finding of blood glucose level


subject: CHEBI:30849

subject_name: L-arabinose


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: Hyperkalemia, CTCAE


subject: UMLS:C1321801

object_name: Hyperkalemia


subject: UMLS:C1321801

object_name: Chronic kidney disease requiring chronic dialysis


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C0225326


subject: UMLS:C0225326


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0770694

object_name: acute myeloid leukemia


subject: UMLS:C0770694

object_name: Myelodysplasia


subject: UMLS:C0770694

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0770694

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0770694

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:177799

subject_name: Larazotide

object_name: celiac disease


subject: UNII:ZN3R5560ZV

subject_name: LARAZOTIDE


subject: CHEBI:34945

object_name: Constipation


subject: CHEBI:34945

object_name: Constipation, CTCAE


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UNII:7662KG2R6K


subject: CHEBI:135920

subject_name: Fesoterodine

object_name: autonomic dysreflexia


subject: UMLS:C0527325

object_name: coronary artery disorder


subject: UMLS:C0527325

object_name: coronary atherosclerosis


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: Bone Demineralization, Pathologic


subject: UNII:TDX7IXK9CU

object_name: stroke disorder


subject: UNII:TDX7IXK9CU

object_name: cerebrovascular disorder


subject: UNII:TDX7IXK9CU

object_name: Stroke (heart beat)


subject: UNII:TDX7IXK9CU

object_name: Stroke, CTCAE


subject: UNII:TDX7IXK9CU

object_name: brain ischemia


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Infection


subject: CHEBI:3732

object_name: infectious disease


subject: CHEBI:3732

object_name: Adverse Event Associated with Infection


subject: CHEBI:5165

subject_name: Fosphenytoin

object_name: epilepsy


subject: UMLS:C0042210

subject_name: Vaccines

object_name: cervical cancer


subject: UMLS:C0042210

object_name: cervical carcinoma


subject: UMLS:C0042210

object_name: Condylomata acuminata in women


subject: UMLS:C0042210

object_name: Genital warts


subject: UMLS:C0042210

object_name: Condylomata acuminata in men


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UNII:2R985002CT

subject_name: Mexidol

object_name: Ischemic stroke


subject: UMLS:C0128329

subject_name: mexidol


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Locally Advanced Intrahepatic Cholangiocarcinoma


subject: GTOPDB:11376


subject: GTOPDB:11376

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: GTOPDB:11376

object_name: Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8


subject: GTOPDB:11376

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: GTOPDB:11376

object_name: Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C3273042

subject_name: TPO Receptor Agonist ONO-7746

object_name: Chemotherapy-Induced Thrombocytopenia


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Pancreas carcinoma resectable


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: UNII:NY0COC51FI

subject_name: Tradipitant

object_name: Coronavinae infectious disease


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:30359

subject_name: isopentyl group


subject: CHEBI:16057

subject_name: Dimethylallyl Diphosphate


subject: CHEBI:9907

subject_name: ursodiol

object_name: Indirect Hyperbilirubinemia, Neonatal


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Placenta Previa


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:16335

subject_name: Adenosine

object_name: myocardial infarction


subject: CHEBI:16335

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:16335

object_name: Myocardial Infarction by ECG Finding


subject: UNII:169D1260KM

subject_name: NITROPRUSSIDE


subject: UNII:169D1260KM


subject: UNII:169D1260KM


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: PUBCHEM.COMPOUND:129696905


subject: CHEBI:16664

subject_name: Albendazole

object_name: schistosomiasis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: uterine sarcoma


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: insulin-resistance syndrome type A


subject: PUBCHEM.COMPOUND:73151030

object_name: insulin-resistance syndrome type B


subject: PUBCHEM.COMPOUND:73151030

object_name: abdominal obesity-metabolic syndrome


subject: PUBCHEM.COMPOUND:73151030

object_name: Insulin resistance syndrome


subject: PUBCHEM.COMPOUND:73151030

object_name: congenital generalized lipodystrophy


subject: PUBCHEM.COMPOUND:73151030

object_name: lipoatrophic diabetes


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Irritable heart


subject: CHEBI:31401

subject_name: Cilostazol

object_name: brain ischemia


subject: CHEBI:31401

object_name: Intracranial hemorrhage


subject: CHEBI:8988

object_name: central nervous system cancer


subject: CHEBI:8988

object_name: Childhood Brain Neoplasm


subject: CHEBI:8988

object_name: Recurrent Brain Neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC


subject: UNII:7RPW6SU9SC

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:31547

subject_name: Eplerenone

object_name: HIV infection


subject: PUBCHEM.COMPOUND:152165

object_name: female infertility


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:15551

subject_name: Dinoprostone


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: amyloidosis


subject: UMLS:C1709429


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:74947

subject_name: Thalidomide


subject: UMLS:C5667024

object_name: pancreatic neoplasm


subject: UMLS:C5667024

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667024

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667024

object_name: Effects of chemotherapy


subject: CHEBI:47426

subject_name: Furosemide

object_name: hypertension


subject: CHEBI:47426

object_name: Hypertension, CTCAE


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:175901

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:175901

object_name: glioma


subject: CHEBI:175901

object_name: malignant glioma


subject: CHEBI:175901

object_name: brain glioma


subject: CHEBI:7772

subject_name: omeprazole

object_name: laryngomalacia


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:11422859

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:11422859

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:11422859

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:11422859

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:11422859

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11422859

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Erythroid Leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:11422859

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:11422859

object_name: Adult Acute Monoblastic and Monocytic Leukemia


subject: CHEBI:28445

subject_name: vincristine

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:43602

subject_name: Obeticholic acid

object_name: Barrett esophagus


subject: CHEBI:43602

object_name: esophageal adenocarcinoma


subject: CHEBI:23359

subject_name: colchicine

object_name: stroke disorder


subject: CHEBI:23359

object_name: cerebrovascular disorder


subject: CHEBI:23359

object_name: Stroke (heart beat)


subject: CHEBI:23359

object_name: Stroke, CTCAE


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: fibromatosis


subject: CHEBI:28748

object_name: desmoid tumor


subject: CHEBI:28748

object_name: Desmoid tumor


subject: CHEBI:70839

subject_name: Dasatinib

object_name: cancer


subject: CHEBI:190514


subject: CHEBI:49375


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C1959590

subject_name: Erythropoiesis Stimulating Agents

object_name: chronic kidney disease


subject: UMLS:C1959590

object_name: Chronic uremia


subject: CHEBI:10545

subject_name: electron


subject: CHEBI:10545


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: UMLS:C0021027

object_name: Guillain-Barre syndrome, familial


subject: UMLS:C0086333

subject_name: Gammagard


subject: UMLS:C0086333


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Acute upper gastrointestinal hemorrhage


subject: CHEBI:2948

subject_name: Azathioprine

object_name: leukemia


subject: CHEBI:2948

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor


subject: PUBCHEM.COMPOUND:24956525


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UMLS:C1268567


subject: UMLS:C1655276

subject_name: T-KI


subject: UMLS:C1655276


subject: PUBCHEM.COMPOUND:137355584

subject_name: Mufemilast

object_name: Behcet disease


subject: UNII:OW6LM47PNK

object_name: central nervous system neoplasm


subject: UNII:OW6LM47PNK

object_name: central nervous system cancer


subject: UNII:OW6LM47PNK

object_name: Recurrent Primary Malignant Central Nervous System Neoplasm


subject: UNII:OW6LM47PNK

object_name: Recurrent Ependymoma


subject: UNII:OW6LM47PNK

object_name: Recurrent Childhood Ependymoma


subject: UNII:OW6LM47PNK

object_name: spinal cord glioma


subject: UNII:OW6LM47PNK

object_name: glioblastoma


subject: UNII:OW6LM47PNK

object_name: Childhood Glioblastoma


subject: UNII:OW6LM47PNK

object_name: adult glioblastoma


subject: CHEBI:71028

subject_name: Carglumic acid

object_name: inborn errors of metabolism


subject: UMLS:C0067889

subject_name: carglumic acid


subject: CHEBI:92712

subject_name: ENDO-ATROPINE

object_name: Constipation by outlet obstruction


subject: CHEBI:91541


subject: CHEBI:3125

subject_name: Bisacodyl


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: kidney disorder


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:45783

subject_name: Imatinib

object_name: Congenital Bone Marrow Failure Syndromes


subject: UNII:TUK9QB44B0

object_name: SAPHO syndrome


subject: UMLS:C5392518


subject: UMLS:C5447414

subject_name: JAK2 Inhibitor TQ05105

object_name: myeloproliferative neoplasm


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: familial hyperprolactinemia


subject: CHEBI:3181

object_name: acquired hyperprolactinemia


subject: CHEBI:3181

object_name: hyperprolactinemia


subject: CHEBI:3181

object_name: schizophrenia


subject: UMLS:C5706438

subject_name: BNA 035

object_name: Adult Solid Neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: B-cell lymphoma refractory


subject: CHEBI:4026

object_name: B-cell lymphoma recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Perinatal pulmonary hemorrhage


subject: CHEBI:94518

object_name: Pulmonary hemorrhage


subject: CHEBI:94518

object_name: Major aortopulmonary collateral artery


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Menorrhagia


subject: UMLS:C0729203

subject_name: Omnipaque

object_name: contrast-induced nephropathy


subject: UMLS:C0729203

object_name: aortic aneurysm


subject: UMLS:C0729203

object_name: Aortic aneurysm without mention of rupture NOS


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:31709


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: infectious disease


subject: CHEBI:195559

subject_name: Poziotinib

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:195559

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:195559

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:195559

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: MESH:C557213


subject: MESH:C557213


subject: MESH:C557213


subject: MESH:C557213


subject: UMLS:C5448077

subject_name: NOV-1201 Hydrochloride


subject: UMLS:C5448077


subject: UMLS:C5448077


subject: UMLS:C5448077


subject: UMLS:C5447492

subject_name: Poziotinib Hydrochloride


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UMLS:C5447492


subject: UNII:X4Z7U6JL1C

subject_name: POZIOTINIB HYDROCHLORIDE


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C


subject: UNII:X4Z7U6JL1C


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: inflammatory bowel disease


subject: CHEBI:6888

object_name: inflammatory bowel disease 1


subject: CHEBI:6888

object_name: Crohn disease


subject: CHEBI:6888

object_name: indeterminate colitis


subject: CHEBI:6888

object_name: ulcerative colitis


subject: UNII:U884AYM4BN

object_name: unspecified adult solid tumor, protocol specific


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors


subject: CHEBI:15365

subject_name: Aspirin

object_name: brain aneurysm


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Carcinoma breast stage IV


subject: UNII:8M7YSN2KII

object_name: Leptomeningeal Neoplasms


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: nephrolithiasis


subject: UMLS:C3273940

subject_name: Copper Cu 64 TP3805

object_name: breast carcinoma


subject: UMLS:C3853900

object_name: Solid Neoplasm


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: abdominal obesity-metabolic syndrome


subject: DRUGBANK:DB14744

object_name: metabolic syndrome X


subject: UMLS:C3254757

subject_name: Chlorella vulgaris extract


subject: UMLS:C3254757


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:231598

object_name: metastatic prostate carcinoma


subject: CHEBI:32599

object_name: brain neoplasm


subject: CHEBI:32599

object_name: Seizures (incl subtypes)


subject: PUBCHEM.COMPOUND:24892726

subject_name: Glucomannan

object_name: Overweight


subject: GTOPDB:10197

subject_name: vantictumab


subject: UNII:88WBI2D80S

subject_name: VANTICTUMAB


subject: UMLS:C3273041

subject_name: Vantictumab


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: Gastric carcinoma stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297836

subject_name: MODAKAFUSP ALFA

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL4297836

object_name: neoplasm


subject: UMLS:C4682934


subject: UMLS:C4682934


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: hemophagocytic syndrome


subject: UMLS:C1446777

subject_name: Rabbit antigen


subject: UMLS:C2093603

subject_name: Rabbit


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: PUBCHEM.COMPOUND:57656761

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:57656761

object_name: lung disorder


subject: CHEMBL.COMPOUND:CHEMBL3545221


subject: CHEMBL.COMPOUND:CHEMBL3545221


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: CHEBI:31355

object_name: B-cell lymphoma refractory


subject: CHEBI:31355

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEBI:31355

object_name: Refractory Transformed Non-Hodgkin Lymphoma


subject: CHEBI:31355

object_name: B-cell lymphoma recurrent


subject: CHEBI:31355

object_name: Non-Hodgkin's lymphoma transformed recurrent


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: concussion


subject: UNII:NQX9KB6PCL

object_name: Mild Traumatic Brain Injury


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:167204

subject_name: Mosapride

object_name: Heartburn


subject: CHEBI:167204

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: CHEBI:31348

subject_name: Capecitabine

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:31348

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:31348

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:4026

object_name: Breast cancer stage II


subject: CHEBI:4026

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: stage IA breast cancer


subject: CHEBI:4026

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4026

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: HER2 positive breast carcinoma


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Stage IA Breast Cancer AJCC v7


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW

object_name: Stage IB Breast Cancer AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Stage IIIA Breast Carcinoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932

object_name: progesterone-receptor positive breast cancer


subject: PR:000005932

object_name: estrogen-receptor positive breast cancer


subject: PR:000005932

object_name: progesterone receptor-negative breast cancer


subject: PR:000005932

object_name: estrogen receptor-negative breast cancer


subject: PR:000005932

object_name: Breast cancer stage II


subject: PR:000005932

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PR:000005932

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PR:000005932

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PR:000005932

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PR:000005932

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PR:000005932


subject: PR:000005932

object_name: stage IA breast cancer


subject: PR:000005932

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PR:000005932

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PR:000005932

object_name: Stage IB Breast Cancer AJCC v7


subject: PR:000005932

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PR:000005932

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PR:000005932

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:6413

subject_name: Letrozole


subject: CHEBI:6413


subject: CHEBI:6413

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:6413


subject: CHEBI:6413


subject: CHEBI:93775

subject_name: Amethopterin

object_name: HER2 positive breast carcinoma


subject: CHEBI:93775

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:93775

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:93775

object_name: Breast cancer stage II


subject: CHEBI:93775

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:93775

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:93775

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:93775

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:93775

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:93775


subject: CHEBI:93775

object_name: stage IA breast cancer


subject: CHEBI:93775

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:93775

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:93775

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863

object_name: progesterone receptor-negative breast cancer


subject: CHEBI:45863

object_name: estrogen receptor-negative breast cancer


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774


subject: CHEBI:41774

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate

object_name: HER2 positive breast carcinoma


subject: CHEBI:32296

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:32296

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296

object_name: Breast cancer stage II


subject: CHEBI:32296

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:32296

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:32296

object_name: stage IA breast cancer


subject: CHEBI:32296

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:32296

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941

object_name: progesterone receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:16051941

object_name: estrogen receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:16051941

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate

object_name: HER2 positive breast carcinoma


subject: CHEBI:53750

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:53750

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750

object_name: Breast cancer stage II


subject: CHEBI:53750

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:53750

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:53750

object_name: stage IA breast cancer


subject: CHEBI:53750

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:53750

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639

object_name: progesterone receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: estrogen receptor-negative breast cancer


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786

object_name: progesterone-receptor positive breast cancer


subject: CHEBI:93786

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786

object_name: Breast cancer stage II


subject: CHEBI:93786

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:93786

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:93786

object_name: stage IA breast cancer


subject: CHEBI:93786

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:93786

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Inflammatory Hepatocellular Adenoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Advanced cancer


subject: UMLS:C4279586

object_name: tardive dyskinesia


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Neck Carcinoma


subject: UNII:5TAA004E22

object_name: head and neck neoplasm


subject: UNII:5TAA004E22

object_name: head and neck cancer


subject: UNII:5TAA004E22

object_name: stomatitis


subject: UNII:5TAA004E22

object_name: Mucositis Oral, CTCAE


subject: UNII:5TAA004E22

object_name: Radiation Sickness


subject: UNII:5TAA004E22

object_name: tongue cancer


subject: UNII:5TAA004E22

object_name: tongue carcinoma


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Drug usage


subject: CHEBI:135654

subject_name: Imidapril

object_name: hypertension


subject: CHEBI:135654

object_name: Hypertension, CTCAE


subject: CHEBI:135654

object_name: Moderate albuminuria


subject: CHEBI:135654

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Non-small cell lung cancer stage III


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: inflammatory bowel disease


subject: CHEBI:78320

subject_name: Lactic acid

object_name: intracranial hypertension


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: CHEBI:167309

subject_name: Methadone

object_name: brain injury


subject: CHEBI:167309

object_name: brain neoplasm


subject: CHEBI:228488

subject_name: Stiripentol

object_name: Dravet syndrome


subject: CHEBI:228488

object_name: developmental and epileptic encephalopathy, 6A


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Allergy


subject: UNII:62F4AD749Y

object_name: hepatitis C


subject: CHEBI:15940

subject_name: Niacin

object_name: inborn mitochondrial myopathy


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:8499

subject_name: Propranolol

object_name: Sedation


subject: CHEBI:8499

object_name: Sedated


subject: CHEBI:8499

object_name: Mechanical ventilation finding


subject: CHEBI:8499

object_name: Critical Illness


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: sickle cell disease


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:9014

subject_name: Salsalate

object_name: schizophrenia


subject: CHEBI:9014

object_name: Insulin resistance


subject: CHEBI:4672

subject_name: Docetaxel

object_name: colorectal carcinoma


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: lung cancer


subject: CHEBI:47097

object_name: lung neoplasm


subject: CHEBI:47097

object_name: lung carcinoma


subject: CHEBI:47097

object_name: Childhood Breast Carcinoma


subject: CHEBI:47097

object_name: breast carcinoma


subject: CHEBI:47097

object_name: breast cancer


subject: CHEBI:47097

object_name: prostate carcinoma


subject: CHEBI:47097

object_name: prostate cancer


subject: CHEBI:47097


subject: CHEBI:47097

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:47097

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:47097

object_name: sarcoma


subject: CHEBI:47097

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:47097

object_name: soft tissue sarcoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: xerophthalmia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: graft versus host disease


subject: CHEBI:32682

subject_name: L-argininium

object_name: essential hypertension


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:50730

subject_name: Montelukast

object_name: plasma cell myeloma


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Huntington disease


subject: CHEBI:47519

object_name: Alzheimer disease